{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:39:23Z","timestamp":1789756763778,"version":"4.0.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/aci.0b013e328332be33","type":"journal-article","created":{"date-parts":[[2009,10,27]],"date-time":"2009-10-27T03:16:54Z","timestamp":1256613414000},"page":"525-530","source":"Crossref","is-referenced-by-count":43,"title":["Antimicrobial prophylaxis for primary immunodeficiencies"],"prefix":"10.1097","volume":"9","author":[{"given":"Alexandra F","family":"Freeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20210128","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.106.183095","article-title":"Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic fever, endocarditis, and Kawasaki disease committee, Council on Cardiovascular disease in the young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group","volume":"116","author":"Wilson","year":"2007","journal-title":"Circulation"},{"key":"R3-7-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MOP.0b013e3283257d0f","article-title":"Are prophylactic antibiotics indicated after a urinary tract infection?","volume":"21","author":"Mattoo","year":"2009","journal-title":"Curr Opin Pediatrics"},{"key":"R4-7-20210128","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S0264-410X(00)00291-7","article-title":"Otitis media prevention: nonvaccine prophylaxis","volume":"19","author":"Giebink","year":"2001","journal-title":"Vaccine"},{"key":"R5-7-20210128","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1542\/peds.2007-1130","article-title":"Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species","volume":"121","author":"Healy","year":"2008","journal-title":"Pedatrics"},{"key":"R6-7-20210128","first-page":"1","article-title":"Antimicrobial prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.","volume":"4","author":"Gafter-Gvili","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R7-7-20210128","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.clim.2007.03.289","article-title":"Use of prophylactic antibiotics and adjunctive therapies in primary immunodeficiency diseases","volume":"123","author":"Yong","year":"2007","journal-title":"Abstract, FOCIS, published in Clinical Immunology"},{"key":"R8-7-20210128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease: report of a national registry of 368 patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"R9-7-20210128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2141.2007.06880.x","article-title":"Modern management of chronic granulomatous disease","volume":"140","author":"Seger","year":"2008","journal-title":"Br J Haematol"},{"key":"R10-7-20210128","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/infdis\/162.3.723","article-title":"Trimethoprim-sulfamethoxasole prophylaxis in the management of chronic granulomatous disease","volume":"162","author":"Margolis","year":"1990","journal-title":"J Infect Dis"},{"key":"R11-7-20210128","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3476(83)80798-7","article-title":"Continuous therapy with trimethoprim-sulfamethoxasole in patients with chronic granulomatous disease.","volume":"1-","author":"Weening","year":"1983","journal-title":"J Pediatrics"},{"key":"R12-7-20210128","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa021931","article-title":"Itraconazole to prevent fungal infections in chronic granulomatous diseases","volume":"348","author":"Gallin","year":"2003","journal-title":"N Engl J Med"},{"key":"R13-7-20210128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/QCO.0b013e328307c7d9","article-title":"Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent studies","volume":"21","author":"Marr","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"R14-7-20210128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-0-387-72005-0_5","article-title":"Leukocyte adhesion deficiencies: molecular basis, clinical findings, and therapeutic options","volume":"601","author":"Etzioni","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"R15-7-20210128","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jaci.2004.02.001","article-title":"Phagocyte immunodeficiencies and their infections","volume":"113","author":"Rosenzweig","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R16-7-20210128","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.immunol.021908.132649","article-title":"Primary B cell immunodeficiencies: comparisons and contrasts","volume":"27","author":"Conley","year":"2009","journal-title":"Ann Rev Immunol"},{"key":"R17-7-20210128","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","article-title":"Practice parameters for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R18-7-20210128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2249.2008.03851.x","article-title":"Clinical Immunology review series: an approach to the management of pulmonary disease in primary antibody deficiency","volume":"155","author":"Tarzi","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"R19-7-20210128","first-page":"CD004401","article-title":"Antibiotics for the prevention of acute and chronic suppurative otits media in children.","volume":"4","author":"Leach","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R20-7-20210128","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.71.4.524","article-title":"Sulfisoxazole chemoprophylaxis for frequent otitis media","volume":"71","author":"Liston","year":"1983","journal-title":"Pediatrics"},{"key":"R21-7-20210128","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.rmed.2008.06.005","article-title":"Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis","volume":"102","author":"Anwar","year":"2008","journal-title":"Respiratory Med"},{"key":"R22-7-20210128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00151829-200504020-00005","article-title":"The disease-modifying effects of twice-weekly azithromycin in patients with bronchiectasis","volume":"4","author":"Cymbala","year":"2005","journal-title":"Treat Respir Med"},{"key":"R23-7-20210128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425247.3.1.71","article-title":"Aerosolized antibiotics: a critical appraisal of their use","volume":"3","author":"Hagerman","year":"2006","journal-title":"Exp Opin Drug Deliv"},{"key":"R24-7-20210128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1345\/aph.1E099","article-title":"Inhaled tobramycin in noncystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa","volume":"39","author":"Drobnic","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R25-7-20210128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/jamp.2007.0652","article-title":"Aerosolized antibiotics for noncystic fibrosis bronchiectasis","volume":"21","author":"Rubin","year":"2008","journal-title":"J Aerosol Med Pulmon Drug Deliv"},{"key":"R26-7-20210128","first-page":"1420","article-title":"A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis","volume":"127","author":"Scheinberg","year":"2005","journal-title":"Chest"},{"key":"R27-7-20210128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12026-007-0029-8","article-title":"Severe combined immunodeficiency: new advances in diagnosis and treatment","volume":"38","author":"Puck","year":"2007","journal-title":"Immunol Res"},{"key":"R28-7-20210128","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(07)61601-8","article-title":"Velocardiofacial syndrome, diGeorge syndrome: the chromosome 22q11.2 deletion syndromes.","volume":"2007","author":"Kobrynski","year":"2007","journal-title":"Lancet"},{"key":"R29-7-20210128","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1542\/peds.112.4.e325","article-title":"Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (diGeorge\/velocardiofacial syndrome)","volume":"112","author":"Perez","year":"2003","journal-title":"Pediatrics"},{"key":"R30-7-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.iac.2008.01.005","article-title":"The Hyper-IgE syndromes","volume":"28","author":"Freeman","year":"2008","journal-title":"Immunol Allergy Clin N Am"},{"key":"R31-7-20210128","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jaci.2006.12.666","article-title":"Causes of death in hyper-IgE syndrome","volume":"119","author":"Freeman","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R32-7-20210128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcf.2005.05.019","article-title":"Buchdahl, et al. Voriconazole therapy in children with cystic fibrosis.","volume":"4","author":"Hilliard","year":"2005","journal-title":"J Cyst Fibrosis"},{"key":"R33-7-20210128","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.rmed.2004.07.002","article-title":"Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment","volume":"98","author":"Wark","year":"2004","journal-title":"Respiratory Med"},{"key":"R34-7-20210128","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2006.01548.x","article-title":"Voriconazole prophylaxis in lung transplant recipients","volume":"6","author":"Husain","year":"2006","journal-title":"Am J Transplant"},{"key":"R35-7-20210128","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.transproceed.2008.09.020","article-title":"Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation","volume":"40","author":"Borro","year":"2008","journal-title":"Transplant Proc"},{"key":"R36-7-20210128","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.micinf.2005.10.029","article-title":"Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling","volume":"8","author":"Haverkamp","year":"2006","journal-title":"Microbes Infect"},{"key":"R37-7-20210128","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00431-006-0339-1","article-title":"Adjunctive treatment of disseminated Mycobacterium avium complex infection with interferon-alpha 2B in a patient with complete interferon-gamma R1 deficiency","volume":"166","author":"Ward","year":"2007","journal-title":"Eur J Pediatrics"},{"key":"R38-7-20210128","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2004.01.762","article-title":"The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation","volume":"113","author":"Orange","year":"2004","journal-title":"J Allergy Clin Immunol"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ACI.0b013e328332be33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:06:32Z","timestamp":1786039592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130832-200912000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e328332be33","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}